Researchers validate link between genetic variant and poor outcomes in advanced prostate cancer
In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that a testosterone-related genetic variant—HSD3B1(1245C) - is associated with more aggressive disease and shorter survival in men with metastatic ...
Feb 13, 2020
0
15